These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 39414354
1. Paternal metformin use and risk of congenital malformations in offspring in Norway and Taiwan: population based, cross national cohort study. Meng LC, van Gelder MMHJ, Chuang HM, Chen LK, Hsiao FY, Nordeng HME. BMJ; 2024 Oct 16; 387():e080127. PubMed ID: 39414354 [Abstract] [Full Text] [Related]
2. Paternal Use of Metformin During the Sperm Development Period Preceding Conception and Risk for Major Congenital Malformations in Newborns. Rotem RS, Weisskopf MG, Huybrechts KF, Hernández-Díaz S. Ann Intern Med; 2024 Jul 16; 177(7):851-861. PubMed ID: 38885501 [Abstract] [Full Text] [Related]
5. Metformin Use in the First Trimester of Pregnancy and Risk for Nonlive Birth and Congenital Malformations: Emulating a Target Trial Using Real-World Data. Chiu YH, Huybrechts KF, Patorno E, Yland JJ, Cesta CE, Bateman BT, Seely EW, Hernán MA, Hernández-Díaz S. Ann Intern Med; 2024 Jul 16; 177(7):862-870. PubMed ID: 38885505 [Abstract] [Full Text] [Related]
9. Congenital malformations in pregnancies complicated by NIDDM. Towner D, Kjos SL, Leung B, Montoro MM, Xiang A, Mestman JH, Buchanan TA. Diabetes Care; 1995 Nov 16; 18(11):1446-51. PubMed ID: 8722068 [Abstract] [Full Text] [Related]
10. Risk of major congenital malformations in relation to maternal overweight and obesity severity: cohort study of 1.2 million singletons. Persson M, Cnattingius S, Villamor E, Söderling J, Pasternak B, Stephansson O, Neovius M. BMJ; 2017 Jun 14; 357():j2563. PubMed ID: 28615173 [Abstract] [Full Text] [Related]
11. Risk of Adverse Pregnancy Outcome After Paternal Exposure to Methotrexate Within 90 Days Before Pregnancy. Eck LK, Jensen TB, Mastrogiannis D, Torp-Pedersen A, Askaa B, Nielsen TK, Poulsen HE, Jimenez-Solem E, Andersen JT. Obstet Gynecol; 2017 Apr 14; 129(4):707-714. PubMed ID: 28277353 [Abstract] [Full Text] [Related]
12. Association of pregnancy outcomes in women with type 2 diabetes treated with metformin versus insulin when becoming pregnant. Lin SF, Chang SH, Kuo CF, Lin WT, Chiou MJ, Huang YT. BMC Pregnancy Childbirth; 2020 Sep 04; 20(1):512. PubMed ID: 32887578 [Abstract] [Full Text] [Related]
16. Metformin and primary bone cancer risk in Taiwanese patients with type 2 diabetes mellitus. Tseng CH. Bone; 2021 Oct 04; 151():116037. PubMed ID: 34116220 [Abstract] [Full Text] [Related]
18. A higher risk of congenital anomalies in the offspring of personnel who served aboard a Norwegian missile torpedo boat. Mageroy N, Mollerlokken OJ, Riise T, Koefoed V, Moen BE. Occup Environ Med; 2006 Feb 04; 63(2):92-7. PubMed ID: 16421386 [Abstract] [Full Text] [Related]
19. Metformin Versus Insulin and Risk of Major Congenital Malformations in Pregnancies With Type 2 Diabetes: A Nordic Register-Based Cohort Study. Kjerpeseth LJ, Cesta CE, Furu K, Engeland A, Gissler M, Gulseth HL, Karlstad Ø, Leinonen MK, Pazzagli L, Zoega H, Cohen JM. Diabetes Care; 2023 Aug 01; 46(8):1556-1564. PubMed ID: 37343541 [Abstract] [Full Text] [Related]
20. Use of metformin and risk of kidney cancer in patients with type 2 diabetes. Tseng CH. Eur J Cancer; 2016 Jan 01; 52():19-25. PubMed ID: 26630530 [Abstract] [Full Text] [Related] Page: [Next] [New Search]